Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorderPANDE, A. C; GREINER, M; ADAMS, J. B et al.Biological psychiatry (1969). 1999, Vol 46, Num 6, pp 860-862, issn 0006-3223Article

Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorderYAMADA, K; HATTORI, E; SHIMIZU, M et al.Journal of neural transmission. 2001, Vol 108, Num 7, pp 837-848, issn 0300-9564Article

The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptorDUNLOP, J; PASS, I; ENNIS, C et al.Neuropeptides (Edinburgh). 1998, Vol 32, Num 2, pp 157-160, issn 0143-4179Article

Association of enkephalin catabolism inhibitors and CCK-B antagonists : A potential use in the management of pain and opioid additionROQUES, B. P; NOBLE, F.Neurochemical research. 1996, Vol 21, Num 11, pp 1397-1410, issn 0364-3190Article

Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cordANTUNES BRAS, J. M; LAPORTE, A.-M; BENOLIEL, J. J et al.Journal of neurochemistry. 1999, Vol 72, Num 2, pp 858-867, issn 0022-3042Article

Glycine-extended gastrin regulates HEK cell growthSTEPAN, V. M; KRAMETTER, D. F; MATSUSHIMA, M et al.American journal of physiology. Regulatory, integrative and comparative physiology. 1999, Vol 46, Num 2, pp R572-R581, issn 0363-6119Article

The cholecystokinin_B receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteinsPOMMIER, B; NASCIMENTO, S. D; DUMONT, S et al.Journal of neurochemistry. 1999, Vol 73, Num 1, pp 281-288, issn 0022-3042Article

Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptorsGUSTAFSSON, H; DE ARAUJO LUCAS, G; SCHÖTT, E et al.Brain research. 1998, Vol 790, Num 1-2, pp 141-150, issn 0006-8993Article

Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsitesLENA, I; ROQUES, B. P; DURIEUX, C et al.Journal of neurochemistry. 1997, Vol 68, Num 1, pp 162-168, issn 0022-3042Article

cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleateBLACKER, D; BROBERGER, C; ÖGREN, S.-O et al.Neuroscience. 1997, Vol 76, Num 4, pp 1057-1067, issn 0306-4522Article

Characterization of cholecystokinin_A and cholecystokinin_B receptors expressed by vagal afferent neuronsMORIARTY, P; DIMALINE, R; THOMPSON, D. G et al.Neuroscience. 1997, Vol 79, Num 3, pp 905-913, issn 0306-4522Article

The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibitionRASMUSSEN, K; GATES, M. R; BURGER, J. E et al.Neuroscience letters. 1997, Vol 222, Num 1, pp 61-64, issn 0304-3940Article

Involvement of CCK in the paraventricular nucleus of the hypothalamus in the cns regulation of colonic motilityMÖNNIKES, H; TEBBE, J; GROTE, C et al.Digestion. 2000, Vol 62, Num 2-3, pp 178-184, issn 0012-2823Article

Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreasSAILLAN-BARREAU, C; DUFRESNE, M; TARASOVA, N et al.Diabetes (New York, NY). 1999, Vol 48, Num 10, pp 2015-2021, issn 0012-1797Article

Effects of the CCK_B antagonist CI-988 on responses to mCPP in generalized anxiety disorderGODDARD, A. W; WOODS, S. W; MONEY, R et al.Psychiatry research. 1999, Vol 85, Num 3, pp 225-240, issn 0165-1781Article

Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in ratsVALVERDE, O; ROQUES, B. P.Neuroscience letters. 1998, Vol 244, Num 1, pp 37-40, issn 0304-3940Article

The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic miceKAMEI, Junzo; ZUSHIDA, Ko.Brain research. 2001, Vol 892, Num 2, pp 370-375, issn 0006-8993Article

Cholecystokinin_B receptor antagonist increases food intake in ratsDORRE, D; SMITH, G. P.Physiology & behavior. 1998, Vol 65, Num 1, pp 11-14, issn 0031-9384Article

CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal levelXU, X.-J; ELFVIN, A; HAO, J.-X et al.Neuropeptides (Edinburgh). 1997, Vol 31, Num 3, pp 287-291, issn 0143-4179Article

Synthesis and biological evaluation of new 3-aralkylamino-2-aryl-2H-1,2,4-pyridothiadiazine 1,1-dioxides as potential CCK-receptor ligandsDE TULLIO, P; PIROTTE, B; NEVEN, P et al.Journal of pharmacy and pharmacology. 1997, Vol 49, Num 5, pp 463-471, issn 0022-3573Article

Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growthKAUFMANN, R; SCHAFBERG, H; RUDROFF, C et al.Neuropeptides (Edinburgh). 1997, Vol 31, Num 6, pp 573-583, issn 0143-4179Conference Paper

Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorderBRAWMAN-MINTZER, O; LYDIARD, R. B; BRADWEJN, J et al.The American journal of psychiatry. 1997, Vol 154, Num 5, pp 700-702, issn 0002-953XArticle

Investigation of genetic risk factors associated with alcoholismHARADA, S; OKUBO, T; TSUTSUMI, M et al.Alcoholism, clinical and experimental research. 1996, Vol 20, Num 9, pp 293A-296A, issn 0145-6008, SUPConference Paper

Antinociceptive effect of U-50488H, a κ-opioid agonist, in streptozotocin-induced diabetic miceSUZUKI, Yasuyuki; GOTO, Kazuhiro; SHIIZAKI, Kazuhiro et al.Journal of pharmacy and pharmacology. 2001, Vol 53, Num 4, pp 521-526, issn 0022-3573Article

Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or Pancreatic secretion or Pancreatic growth : A study in CCK-B receptor gene knockout miceMIYASAKA, K; SHINOZAKI, H; KONO, A et al.Pancreas. 1999, Vol 19, Num 2, pp 114-118, issn 0885-3177Article